🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a research study designed to evaluate the rate and extent of absorp...
Status
Completed
Location
LLC "Scientific and Research centre Eco-safety"
Start Date
2018-12-03
Trial ID
NCT03697889
Treatments Being Tested
The purpose of this study is to assess the bioequivalence of Naproxen sodiu...
Status
Completed
Location
Lotus Labs Private Limited
Start Date
2004-07
Trial ID
NCT01131728
Treatments Being Tested
To compare the pharmacokinetic profile of the proposed extended- release ta...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT00969449
Treatments Being Tested
The purpose of this study is to determine whether the absorption of naproxe...
Status
Completed
Location
Research Site
Start Date
2009-09
Trial ID
NCT00992381
LT-NS001 is a prodrug of Naproxen, which is inactive as a cox inhibitor whi...
Status
Completed
Location
Greystone Medical Research, LLC
Start Date
2010-02
Trial ID
NCT01063920
The goal of this study is to measure medical resource utilization, treatmen...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01381523
The Sponsor is developing a new form of naproxen (the study drug, OXP005), ...
Status
Completed
Location
Quotient Clinical Ltd
Start Date
2015-02
Trial ID
NCT02351024
The purpose of the study is to better understand the factors present in the...
Status
Completed
Location
Outpatient Care Center
Start Date
2015-08
Trial ID
NCT02451748
To compare the safety and efficacy of celecoxib versus placebo in the treat...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2003-12
Trial ID
NCT00640627
The purpose of this study is to assess the bioequivalence of Naproxen sodiu...
Status
Completed
Location
Lotus Labs Private Limited
Start Date
2004-07
Trial ID
NCT01131767
Treatments Being Tested